Physician profile
Catherine King
NPI 1225236862
$2,054.81
in general payments reported to CMS, 2019-2025
19 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $450 · 2022: $566 · 2023: $182 · 2024: $426 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,123.66 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $213.00 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $170.57 | 2022-2024 | Mounjaro, Zepbound |
| Acadia Pharmaceuticals INC | $76.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $70.42 | 2021-2024 | Spravato |
| Dexcom, INC. | $68.40 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $49.11 | 2022 | |
| Medline Industries LP | $43.83 | 2025 | |
| Abbvie INC. | $38.38 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $34.44 | 2021 | |
| Amgen INC. | $26.46 | 2025 | Krystexxa |
| Medtronic, INC. | $22.90 | 2021 | |
| Nevro Corp. | $22.36 | 2022 | |
| Amarin Pharma, INC. | $19.78 | 2021 | |
| Sanofi Pasteur INC. | $18.75 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.24 | 2022 | |
| Eisai INC. | $13.94 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.97 | 2022 | |
| Glaxosmithkline, LLC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.